Trials / Recruiting
RecruitingNCT07339800
Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Invasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest imaging in their diagnosis is well established in the 2020 EORTC/MSGERC criteria, and its use is almost systematic. However, the progression of lung parenchymal involvement and any potential prognostic radiological patterns in the follow-up of these infections are less well understood. This research aims to identify imaging characteristics predictive of favorable or unfavorable outcomes in infected patients, in order to better tailor follow-up and therapeutic options.
Conditions
Timeline
- Start date
- 2025-09-18
- Primary completion
- 2026-09-01
- Completion
- 2026-09-19
- First posted
- 2026-01-14
- Last updated
- 2026-01-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07339800. Inclusion in this directory is not an endorsement.